·1 хв читання · 37 слів·👁 8.6K↗ 17
Singapore biotech Mirxes files for Hong Kong IPO after raising US$50 million
Until recently, Singapore-based Mirxes was caught between listing locally or overseas. The Series D funding values the company at around US$600 million post-money, BT understands.


